ICCM News and Press, IceCure Medical Ltd. From 12/05/25

IceCure Receives Notice of Patent Allowance in China for a Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes PR Newswire Cryogenic flow control enhances the efficacy and precision of cryoablation procedures Robust IP portfolio becomes increasingly strategic a...

2025-11-19 12:53:28 ET IceCure Medical Ltd (ICCM) Q3 2025 Earnings Call November 19, 2025 10:00 AM EST Company Participants Eyal Shamir - CEO & Director Ronen Tsimerman - Chief Financial Officer Conference Call Participants Michael Polyviou - EVC Gr...

2025-11-19 08:56:59 ET More on IceCure Medical IceCure Medical Ltd (ICCM) U.S. Food And Drug Administration's Marketing Authorization For ProSense Cryoablation Call Transcript Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for IceCure...

IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025 IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025 PR Newswire Momentum building in the U.S. and rising interest globally following landm...

NVIDIA Corporation (NVDA) is expected to report $1.18 for Q3 2026 Kulicke and Soffa Industries Inc. (KLIC) is expected to report $0.07 for Q4 2025 LuxExperience B.V. American Depositary Shares each representing one (LUXE) is expected to report $-0.28 for Q1 2026 RGC Resources Inc. (RG...

IceCure's ProSense® Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer PR Newswire This latest approval further broadens global access to ProSense® and supports IceCure's commercial momentum fol...

IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire CAESAREA, Israel , Nov. 14, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezin...

IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025 PR Newswire CAESAREA, Israel , Nov. 12, 2025 /PRNewswire/ --  IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-in...

IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction PR Newswire Mr. Levav's appointment ensures seamless and focused organizational structure as Company expands commercial activities in the U.S. following FDA marketing cleara...

IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival PR Newswire 5-year overall survival (OS) rate for stereotactic body radiation therapy (SBRT) followed by cryoablation was 7...